Disappointing lessons from “The Biggest Loser” participants’ experiences six years later.

Why Novo Nordisk and Sanofi’s combination drugs are potential gamechangers for type 2 diabetes.

Use 4 mm needles, rotate injection sites, and more – why the little stuff matters

A UCLA study offers alarming insights into the nation’s diabetes epidemic.

Plus, what people with diabetes and healthcare providers can do

A run-down on insurance and other payment assistance programs for medical services and prescription medicines

What to do if you have United insurance.

What does A1c miss and what can we do about it?

Our own Kelly Close moderates a panel at SXSW Interactive.

People with type 2 diabetes should contact their physicians if they notice new pain, sores, or infections on their legs or feet.

LEADER results announced at #2016ADA – compared to placebo, Victoza reduces risk of cardiovascular death by 22%, plus a 22% reduction in kidney disease. More results...

Sept. 28 was a big day for diabetes tech approvals in the US – a big step in bringing the latest and greatest tech to people with diabetes!

Details on monthly test strip subscription plan and our first impressions.

How I’m trying to beat my long list of “I should really...”

What to look for when comparing plans in the healthcare.gov insurance marketplace

Free for patients! Initially available in Austria and Germany, and soon in the US.

People with type 2 diabetes are far more willing than their doctors perceive to take action to achieve A1c goals

“We have to create solutions in diabetes that are as addictive as the iPhone.”

“We need to support people at risk and prevent diabetes before it even happens.”

Team Novo Nordisk athletes with diabetes dispel myths and stigma.